Abstract
The article presents an overview of NEPTUNO’s own survey and research on the pharmacoeconomic analysis of the use of the polypill strategy.
 In the NEPTUNO study, it was shown that the use of a cardiovascular polypill containing acetylsalicylic acid, ramipril, atorvastatin (CNIC-Polypill – Trinomy) resulted in significantly lower use of health care resources compared to control groups; significantly lower total and direct medical costs. And this, in turn, led to a decrease in hospitalizations, cardiovascular events and the number of visits to the doctor.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
